Literature DB >> 17000979

Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.

Kerstin Imrell1, Anne-Marie Landtblom, Jan Hillert, Thomas Masterman.   

Abstract

We sought to determine whether Swedish patients with multiple sclerosis (MS) with and without oligoclonal bands (OCBs) in the CSF constitute distinct subpopulations, clinically and immunogenetically. Our findings indicate that OCB-negative MS shares the same clinical features as OCB-positive MS regarding female predominance, age at onset, proportion of primary progressive cases, rate of MRI positivity, and disease severity. Our HLA-DRB1 genotyping results suggest, however, that OCB-positive and OCB-negative MS are immunogenetically distinct.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000979     DOI: 10.1212/01.wnl.0000237343.93389.35

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.

Authors:  An Goris; Ine Pauwels; Marte W Gustavsen; Brechtje van Son; Kelly Hilven; Steffan D Bos; Elisabeth Gulowsen Celius; Pål Berg-Hansen; Jan Aarseth; Kjell-Morten Myhr; Sandra D'Alfonso; Nadia Barizzone; Maurizio A Leone; Filippo Martinelli Boneschi; Melissa Sorosina; Giuseppe Liberatore; Ingrid Kockum; Tomas Olsson; Jan Hillert; Lars Alfredsson; Sahl Khalid Bedri; Bernhard Hemmer; Dorothea Buck; Achim Berthele; Benjamin Knier; Viola Biberacher; Vincent van Pesch; Christian Sindic; Annette Bang Oturai; Helle Bach Søndergaard; Finn Sellebjerg; Poul Erik H Jensen; Manuel Comabella; Xavier Montalban; Jennifer Pérez-Boza; Sunny Malhotra; Jeannette Lechner-Scott; Simon Broadley; Mark Slee; Bruce Taylor; Allan G Kermode; Pierre-Antoine Gourraud; Stephen J Sawcer; Bettina Kullle Andreassen; Bénédicte Dubois; Hanne F Harbo
Journal:  Brain       Date:  2015-01-22       Impact factor: 13.501

Review 2.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Authors:  Martin Stangel; Sten Fredrikson; Edgar Meinl; Axel Petzold; Olaf Stüve; Hayrettin Tumani
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

3.  Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.

Authors:  Denis A Akkad; Barbara Bellenberg; Sarika Esser; Florian Weiler; Jörg T Epplen; Ralf Gold; Carsten Lukas; Aiden Haghikia
Journal:  Neurogenetics       Date:  2015-01-27       Impact factor: 2.660

4.  Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.

Authors:  Maria Anagnostouli; Foteini Christidi; Ioannis Zalonis; Chryssoula Nikolaou; Dimitrios Lyrakos; Nikolaos Triantafyllou; Ioannis Evdokimidis; Constantinos Kilidireas
Journal:  Neurol Sci       Date:  2015-07-01       Impact factor: 3.307

5.  Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.

Authors:  Hanne F Harbo; Noriko Isobe; Pål Berg-Hansen; Steffan D Bos; Stacy J Caillier; Marte W Gustavsen; Inger-Lise Mero; Elisabeth Gulowsen Celius; Stephen L Hauser; Jorge R Oksenberg; Pierre-Antoine Gourraud
Journal:  Mult Scler       Date:  2013-10-07       Impact factor: 6.312

6.  MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns.

Authors:  Hagen B Huttner; Peter D Schellinger; Tobias Struffert; Gregor Richter; Tobias Engelhorn; Teresa Bassemir; Mathias Mäurer; Meritxell Garcia; Stefan Schwab; Martin Köhrmann; Arnd Doerfler
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

Review 7.  The evidence for a role of B cells in multiple sclerosis.

Authors:  G Disanto; J M Morahan; M H Barnett; G Giovannoni; S V Ramagopalan
Journal:  Neurology       Date:  2012-03-13       Impact factor: 9.910

8.  Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study.

Authors:  Virginija Danylaité Karrenbauer; Sahl Khalid Bedri; Jan Hillert; Ali Manouchehrinia
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

9.  Progress in multiple sclerosis genetics.

Authors:  An Goris; Ine Pauwels; Bénédicte Dubois
Journal:  Curr Genomics       Date:  2012-12       Impact factor: 2.236

10.  Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients.

Authors:  Maurizio A Leone; Nadia Barizzone; Federica Esposito; Ausiliatrice Lucenti; Hanne F Harbo; An Goris; Ingrid Kockum; Annette Bang Oturai; Elisabeth Gulowsen Celius; Inger L Mero; Bénédicte Dubois; Tomas Olsson; Helle Bach Søndergaard; Daniele Cusi; Sara Lupoli; Bettina Kulle Andreassen; Kjell-Morten Myhr; Franca R Guerini; Giancarlo Comi; Filippo Martinelli-Boneschi; Sandra D'Alfonso
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.